ADARB1 and amyotrophic lateral sclerosis: As the RNA editing efficiency at the ADAR2 sites in extracellular RNAs reflects intracellular ADAR2 activity in vitro [147], demonstrating a reduction in the editing levels of these RNAs in the cerebrospinal fluid would become a biomarker for ALS.